Dedicated Expertise.

Medical device companies are facing more challenges than ever. A changing regulatory landscape makes bringing devices and diagnostics to market difficult; planning missteps cost you time and money. Each day Novella Clinical helps device, diagnostic and drug/device combination sponsors navigate regulatory hurdles and provides guidance from regulatory assessments to post-marketing strategies.

But perhaps the most satisfying work lies in between – designing and executing clinical trials. As one of the largest CROs supporting medical device sponsors, Novella has the global footprint and clinical depth to expertly guide you through the clinical trial process, resulting in the clinical data critical to moving your product forward. 

And for over a decade we have been helping sponsors do just that – bring products to those who need them. Although our clinical experience is all-inclusive, our therapeutic concentrations for device and diagnostics include cardio/vascular, orthopedic/spine, general surgery and oncology.

Novella is proud to have earned preferred vendor status with two of the top five medical device companies due to our outstanding operational execution, quality management program including ISO 9001:2008 certification, and superior client satisfaction ratings.

White Paper
Medical Device White Paper: Best Practices for Interventional Cardiovascular Medical Device Trials
Download White Paper


Med Tech News

by AdvaMed SmartBrief

Spinal implant firm raises IPO target to about $183M
Virginia-based K2M, which specializes in implantable spinal devices, announced that it could pull in as much as $183 million  -More

WEBINAR: Training Management Best Practices for Emerging Life Science Companies | May 1, 2014
Join us for a one hour look at Training Management Best Practices for initiating and implementing an electronic training management solution for start-up and emerging Life Science organizations. See how using a powerful configurable solution can help you meet your training management needs and more, allowing your organization to efficiently utilize the right resources at the right time. Register now!

Funding round pulls in $30M for Guardant Health
A Series B funding round led by Khosla Ventures has brought in $30 million for Guardant Health, a startup developing next-gen -More
Amendia sells cervical spinal surgery devices to Medline
Amendia has agreed to sell its anterior cervical fusion distraction pin assets to Medline Industries for undisclosed terms.  -More